The regulation of PI3K/AKT, JAK/STAT, and MAPK signaling pathways has been linked to sesamin's tumor-inhibitory activities, mediated by some typical receptor estrogen, HER2, and EGFR. This evidence concerns the gene SOAT1 and neoplasm.